Assessment of Swallowing Function and Quality of Life in Oropharyngeal Cancer Patients Treated by Chemo-radiotherapy

Open-label, interventional, multicentric, randomized, phase III study. Cancer studied is the oropharyngeal cancer. Study is composed by 2 arms of subjects: prophylactic or reactive percutaneous endoscopic gastrostomy tube placement. All subjects will be treated with a cisplatin standard chemotherapy regimen and by simultaneous integrated boost (SIB) intensity modulated radiotherapy (IMRT).

Trial Details

NCT ID
NCT04019548
Phase
PHASE3
Sponsor
Jules Bordet Institute
Status
RECRUITING
Cancer Type
Head and Neck Cancer
Interventions
  • Percutaneous Endoscopic Gastrotomy tube placement
  • Cisplatin injection
  • Radiotherapy
Locations (sample)
  • Brussels, Belgium|50.85045,4.34878
  • Brussels, Belgium|50.85045,4.34878

Key Eligibility Criteria

  • Age ≥ 18 years old
  • ECOG performance status ≤ 2
  • Female and Male
  • Newly diagnosed, histologically confirmed primary squamous cell carcinoma of the oropharynx

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Head and Neck Cancer Trials on Trialify →